journal article·2020-06-08

Expansion of Ovarian Cancer Stem-like Cells in Poly(ethylene glycol)-Cross-Linked Poly(methyl vinyl ether-alt-maleic acid) and Alginate Double-Network Hydrogels

Naizhen Zhou, Xiaoe Ma, Katrien V. Bernaerts, Pengfei Ren, Wanjun Hu, Tianzhu Zhang

Publisher page

Abstract

A better understanding of cancer stem cells (CSCs) is essential for research on cancer therapy and drug resistance. Currently, increasingly more investigations are focused on obtaining CSCs to study the mechanism of their enhanced malignancy. In this work, three kinds of double-network hydrogels (PEMM/alginate), consisting of poly(ethylene glycol) (PEG) covalently cross-linked poly(methyl vinyl ether-alt-maleic acid) (P(MVE-alt-MA)) (network 1, denoted as PEMM) and Sr2+ (or Ca2+, Fe3+) ionically cross-linked alginates (network 2, denoted as SrAlg, CaAlg, or FeAlg), were prepared. The stiffness, morphology, and components of the PEMM/alginate hydrogels were systematically investigated to understand their effects on CSC enrichment. Only the PEMM/FeAlg hydrogels could support the long-term growth, proliferation, and spheroid formation of SK-OV-3 cells. The expression of CSC-related markers was evaluated with the levels of protein and gene at different stages. The cell spheroids cultured in the PEMM/FeAlg hydrogels acquired certain CSC-like properties, thus drug resistance was enhanced, especially in the PEMM-1/FeAlg hydrogel. In vivo tumorigenicity experiments also confirmed the presence of more CSCs in the PEMM-1/FeAlg hydrogel. The results suggest that matrix stiffness, morphology, and cations act synergistically on the regulation of the epithelial–mesenchymal transition (EMT), interleukin-6 (IL-6), and Wnt pathways, affecting the invasiveness of ovarian cancer and the conversion of the non-CSCs into CSCs. The PEMM-1/FeAlg hydrogel with lower elastic modulus, a more macroporous morphology, and higher swelling rate can significantly enhance the stemness, malignancy, and tumorigenicity of SK-OV-3 cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Lab of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China

Aachen-Maastricht Institute for Biobased Materials (AMIBM), Faculty of Science and Engineering, Maastricht University, Brightlands Chemelot Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands

Funding

Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application

References (85)

Show source-provided references
1. 10.1016/j.ejmech.2017.06.03010.1016/j.ejmech.2017.06.030 ↗
2. 10.1016/j.pmu.2015.03.00710.1016/j.pmu.2015.03.007 ↗
3. 10.5483/BMBRep.2018.51.10.04210.5483/BMBRep.2018.51.10.042 ↗
4. 10.1586/erm.12.11710.1586/erm.12.117 ↗
5. 10.4161/cam.2129410.4161/cam.21294 ↗
6. 10.1016/j.ctrv.2016.07.00110.1016/j.ctrv.2016.07.001 ↗
7. 10.1016/j.biomaterials.2015.11.03110.1016/j.biomaterials.2015.11.031 ↗
8. 10.18632/oncotarget.851510.18632/oncotarget.8515 ↗
9. 10.1039/c2ib20034a10.1039/c2ib20034a ↗
10. 10.1016/j.actbio.2016.04.03210.1016/j.actbio.2016.04.032 ↗
11. 10.1021/acs.biomac.7b0062710.1021/acs.biomac.7b00627 ↗
12. 10.1016/j.carbpol.2017.12.01310.1016/j.carbpol.2017.12.013 ↗
13. 10.1016/j.cis.2014.03.00910.1016/j.cis.2014.03.009 ↗
14. 10.1021/bm060010d10.1021/bm060010d ↗
15. 10.1155/2012/82051310.1155/2012/820513 ↗
16. 10.1002/adfm.20180843910.1002/adfm.201808439 ↗
17. 10.1007/s10856-018-6113-x10.1007/s10856-018-6113-x ↗
18. 10.1088/1748-6041/4/2/02500810.1088/1748-6041/4/2/025008 ↗
19. 10.1016/j.carbpol.2015.05.02110.1016/j.carbpol.2015.05.021 ↗
20. 10.1016/j.jconrel.2008.10.01910.1016/j.jconrel.2008.10.019 ↗
21. 10.1089/ten.tec.2012.048910.1089/ten.tec.2012.0489 ↗
22. 10.1016/j.jbiotec.2014.02.01610.1016/j.jbiotec.2014.02.016 ↗
23. 10.1016/j.biomaterials.2014.06.01110.1016/j.biomaterials.2014.06.011 ↗
24. 10.1038/nmeth.167110.1038/nmeth.1671 ↗
25. 10.1016/j.jcis.2018.08.06410.1016/j.jcis.2018.08.064 ↗
26. 10.1002/marc.20130086810.1002/marc.201300868 ↗
27. 10.1016/j.colsurfb.2016.03.00810.1016/j.colsurfb.2016.03.008 ↗
28. 10.1016/j.biomaterials.2010.08.00710.1016/j.biomaterials.2010.08.007 ↗
29. 10.1007/s11095-008-9801-210.1007/s11095-008-9801-2 ↗
30. 10.1016/j.actbio.2018.05.03910.1016/j.actbio.2018.05.039 ↗
31. 10.1016/j.ijbiomac.2017.05.09410.1016/j.ijbiomac.2017.05.094 ↗
32. 10.1016/j.actbio.2014.08.02510.1016/j.actbio.2014.08.025 ↗
33. 10.1016/j.jiec.2016.05.01210.1016/j.jiec.2016.05.012 ↗
34. 10.1166/jnn.2016.1376810.1166/jnn.2016.13768 ↗
35. 10.1021/am403966x10.1021/am403966x ↗
36. 10.1016/j.eurpolymj.2008.12.01910.1016/j.eurpolymj.2008.12.019 ↗
37. 10.1016/j.jmbbm.2017.01.03810.1016/j.jmbbm.2017.01.038 ↗
38. 10.1016/j.carbpol.2017.10.06810.1016/j.carbpol.2017.10.068 ↗
39. 10.1021/bm300420z10.1021/bm300420z ↗
40. 10.1021/acs.jpcb.6b0047210.1021/acs.jpcb.6b00472 ↗
41. 10.1002/app.3652410.1002/app.36524 ↗
42. 10.1016/j.ijbiomac.2018.04.04410.1016/j.ijbiomac.2018.04.044 ↗
43. 10.1016/j.ejpb.2017.04.01810.1016/j.ejpb.2017.04.018 ↗
44. 10.1016/j.biomaterials.2014.08.01510.1016/j.biomaterials.2014.08.015 ↗
45. 10.1016/j.biomaterials.2013.06.05910.1016/j.biomaterials.2013.06.059 ↗
46. 10.1016/j.yexcr.2015.10.03410.1016/j.yexcr.2015.10.034 ↗
47. 10.1002/jcb.2753210.1002/jcb.27532 ↗
48. 10.1038/nature1013710.1038/nature10137 ↗
49. 10.1039/C6TB01713D10.1039/C6TB01713D ↗
50. 10.1016/j.biomaterials.2014.01.02910.1016/j.biomaterials.2014.01.029 ↗
51. 10.1089/ten.tea.2012.033310.1089/ten.tea.2012.0333 ↗
52. 10.1088/1748-6041/8/3/03500410.1088/1748-6041/8/3/035004 ↗
53. 10.1039/c3ib20255k10.1039/c3ib20255k ↗
54. 10.1016/j.canlet.2015.08.01810.1016/j.canlet.2015.08.018 ↗
55. 10.1007/s00018-010-0420-910.1007/s00018-010-0420-9 ↗
56. 10.1002/ijc.2596710.1002/ijc.25967 ↗
57. 10.3892/or_0000076110.3892/or_00000761 ↗
58. 10.1002/lary.2400310.1002/lary.24003 ↗
59. 10.1016/j.yexmp.2011.06.00510.1016/j.yexmp.2011.06.005 ↗
60. 10.1158/0008-5472.CAN-08-036410.1158/0008-5472.CAN-08-0364 ↗
61. 10.18632/oncotarget.1016910.18632/oncotarget.10169 ↗
62. 10.1371/journal.pone.005914710.1371/journal.pone.0059147 ↗
63. 10.1016/j.bbrc.2017.01.11110.1016/j.bbrc.2017.01.111 ↗
64. 10.1002/ijc.2847810.1002/ijc.28478 ↗
65. 10.1074/jbc.M110.19953910.1074/jbc.M110.199539 ↗
66. 10.1016/j.biopha.2018.04.02210.1016/j.biopha.2018.04.022 ↗
67. 10.1016/j.cellsig.2013.01.00710.1016/j.cellsig.2013.01.007 ↗
68. 10.1016/j.biopha.2017.05.02010.1016/j.biopha.2017.05.020 ↗
69. 10.1016/j.ygyno.2013.09.03410.1016/j.ygyno.2013.09.034 ↗
70. 10.1016/j.biomaterials.2014.09.01010.1016/j.biomaterials.2014.09.010 ↗
71. 10.1016/j.biomaterials.2014.07.03710.1016/j.biomaterials.2014.07.037 ↗
72. 10.1371/journal.pone.012297310.1371/journal.pone.0122973 ↗
73. 10.1177/096032711453753610.1177/0960327114537536 ↗
74. 10.1016/j.pbiomolbio.2016.01.00410.1016/j.pbiomolbio.2016.01.004 ↗
75. 10.1039/C3TB21047B10.1039/C3TB21047B ↗
76. 10.1016/j.phrs.2017.03.01810.1016/j.phrs.2017.03.018 ↗
77. 10.1016/j.freeradbiomed.2018.07.01510.1016/j.freeradbiomed.2018.07.015 ↗
78. 10.1016/j.semcancer.2018.07.00910.1016/j.semcancer.2018.07.009 ↗
79. 10.1016/j.ccell.2015.09.00210.1016/j.ccell.2015.09.002 ↗
80. 10.1038/onc.2017.1110.1038/onc.2017.11 ↗
81. 10.1016/j.bbrc.2016.05.06410.1016/j.bbrc.2016.05.064 ↗
82. 10.1152/ajpcell.00322.201510.1152/ajpcell.00322.2015 ↗
83. 10.1016/j.bbrc.2014.01.07910.1016/j.bbrc.2014.01.079 ↗
84. 10.1371/journal.pone.001565510.1371/journal.pone.0015655 ↗
85. 10.1016/j.biomaterials.2013.10.03110.1016/j.biomaterials.2013.10.031 ↗